VeriMomhydrogenated tallowamide dea é seguro durante a gravidez?
No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
Related ingredients
Frequently asked questions
- hydrogenated tallowamide dea é seguro durante a gravidez?
- No EU Annex II/III listing or harmonised CLP CMR classification was found for CAS 68440-32-4 (ECHA substance records list it as 'fatty acids, tallow, reaction products with diethanolamine' but show no harmonised H‑codes). PubChem and ECHA list the substance as a reaction product/mixture; peer‑reviewed reproductive studies specific to hydrogenated tallowamide DEA were not found. Because it is a fatty‑acid diethanolamide (a surfactant/amphiphile) dermal absorption is possible but expected to be low for typical cosmetic use (hence exposure scored 1). Sources: ECHA substance info, PubChem, CIR draft on DEA-related compounds, EWG ingredient page.
- hydrogenated tallowamide dea é seguro durante a amamentação?
- Same evidence basis as for pregnancy: no harmonised classification or specific reproductive/developmental toxicity data were located for this CAS. Theoretical class concerns about DEA‑type substances (e.g., formation of nitrosamines or residual free DEA) are noted in broader DEA discussions but are not specific toxicological proof for this substance. Dermal exposure from cosmetics is low‑to‑measurable; breastfeeding exposure via milk is not demonstrated in the literature for this ingredient.
- hydrogenated tallowamide dea é seguro para a pele do bebê?
- No infant‑specific reproductive or developmental data were identified. Infant skin has higher surface‑area‑to‑weight and immature barrier function, so exposure score is increased by +1 relative to adult (adult e=1 → infant e=2) despite lack of data showing systemic effects. No evidence found that the ingredient is banned/restricted for infant use under EU Cosmetic Regulation.
- Como o VeriMom pontua hydrogenated tallowamide dea?
- O VeriMom pontua hydrogenated tallowamide dea em 93/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a hydrogenated tallowamide dea na gravidez?
- Veja nossa lista curada de alternativas seguras a hydrogenated tallowamide dea com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.